首页 > 市场调查报告书 > 医疗设备

眼科设备

全球无晶体眼市场规模、份额及成长分析（按类型、最终用户、治疗方法和地区）- 产业预测（2025-2032）

市场调查报告书

商品编码

1802012

全球无晶体眼市场规模、份额及成长分析（按类型、最终用户、治疗方法和地区）- 产业预测（2025-2032）

Aphakia Market Size, Share, and Growth Analysis, By Type (Acquired Aphakia, Congenital Aphakia), By End User (Hospitals, Ophthalmic clinics), By Treatment, By Region - Industry Forecast 2025-2032

出版日期: 2025年08月22日 | 出版商:

SkyQuest | 英文 184 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计 2023 年全球无晶体眼市场规模将达到 18 亿美元，并从 2024 年的 20 亿美元成长到 2032 年的 47.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 11.3%。

由于白内障患者数量不断增加、老年人口不断扩大以及眼外伤盛行率不断上升，全球无晶体眼市场正在经历显着增长。事故和运动造成的眼外伤很普遍，通常会导致水晶体脱位，这进一步刺激了市场扩张。水晶体设计的创新增强了视力矫正效果，导致无晶体眼治疗方法广泛采用。此外，人们越来越意识到眼睛健康和早期疗育的重要性，这正在推动市场需求。透过各种措施改善医疗保健的机会正在扩大治疗机会。人工智慧、机器学习、物联网、扩增实境(AR) 和虚拟实境 (VR) 等技术进步正在透过实现先进的病患监测、手术指导和增强的诊断能力来彻底改变市场，从而改善全球患者和医疗保健提供者的治疗效果。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司详情
- 产品系列分析
- 按部门分類的公司份额分析
- 收益同比对比（2022-2024 年）

主要企业简介

Johnson & Johnson Vision（Johnson & Johnson Services Inc.）
Alcon Laboratories Inc.
Carl Zeiss AG（ZEISS International）
Bausch+Lomb Incorporated
Rayner Intraocular Lenses Limited
Ophtec BV
CooperVision Inc.
Hoya Corporation
Menicon Co. Ltd.
Bohus BioTech AB
Lifecore Biomedical, LLC
Mediphacos
Santen Pharmaceutical Co. Ltd.
UltraVision CLPL

结论和建议

简介目录

Product Code: SQMIG35A3108

Global Aphakia Market size was valued at USD 1.8 billion in 2023 and is poised to grow from USD 2.0 billion in 2024 to USD 4.72 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).

The global aphakia market is experiencing significant growth due to a rise in cataract cases, an increasing aging population, and a heightened incidence of eye trauma. The prevalence of eye injuries from accidents and sports often results in lens dislocation, further driving market expansion. Innovations in lens design enhance visual correction, leading to greater adoption of aphakia treatments. Moreover, heightened awareness about eye health and the importance of early intervention boosts market demand. Improved healthcare access through various initiatives fosters widespread treatment opportunities. Technological advancements, including AI, machine learning, IoT, augmented reality, and virtual reality, are revolutionizing the market by enabling sophisticated patient monitoring, surgical guidance, and enhanced diagnostic capabilities, thereby improving outcomes for both patients and healthcare providers globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aphakia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aphakia Market Segments Analysis

Global Aphakia Market is segmented by Type, End User, Treatment and region. Based on Type, the market is segmented into Acquired Aphakia and Congenital Aphakia. Based on End User, the market is segmented into Hospitals, Ophthalmic clinics and Others. Based on Treatment, the market is segmented into Spectacles, Contact Lenses, Intraocular Lens Implantation and Refractive Surgery. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aphakia Market

The global aphakia market is significantly driven by the rising demand for cataract surgeries, which involve the removal of the natural lens from the eye, creating avenues for effective aphakia treatments. As more healthcare professionals prefer surgeries for high-risk cataract patients, the market experiences enhanced growth potential. Furthermore, regions with improved healthcare access are witnessing a surge in aphakia cases, further propelling market expansion. This combination of surgical advancements and increased patient accessibility underscores the robust opportunities for innovation and investment within the aphakia treatment sector on a global scale.

Restraints in the Global Aphakia Market

The global aphakia market faces significant constraints primarily due to the high costs associated with treatment options. Interventions typically involve the use of intraocular lenses, specialized contact lenses, or intricate surgical procedures, all of which can be prohibitively expensive. This financial burden limits access and hinders the adoption of effective therapies for those affected by aphakia. Furthermore, manufacturers encounter difficulties in balancing affordability with the necessary standards of precision and safety, which further complicates efforts to enhance market availability and treatment accessibility. Consequently, these factors collectively contribute to the restricted growth of the aphakia treatment market.

Market Trends of the Global Aphakia Market

The Global Aphakia market is witnessing a significant trend driven by the escalating demand for intraocular lenses (IOLs) as patients and ophthalmologists increasingly recognize their advantages in correcting vision. This surge is further propelled by a broader shift towards minimally invasive surgical techniques, which enhance patient comfort and recovery. As advancements in IOL technology continue to emerge, offering improved visual outcomes and reduced complications, more individuals are opting for these solutions post-cataract surgery. The combination of heightened awareness, technological innovations, and a preference for efficient surgical processes is collectively fostering a robust growth trajectory in the Global Aphakia market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Aphakia Market Size by Type & CAGR (2025-2032)

Market Overview
Acquired Aphakia
Congenital Aphakia

Global Aphakia Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Ophthalmic clinics
Others

Global Aphakia Market Size by Treatment & CAGR (2025-2032)

Market Overview
Spectacles
Contact Lenses
Intraocular Lens Implantation
Refractive Surgery

Global Aphakia Market Size & CAGR (2025-2032)

North America (Type, End User, Treatment)
- US
- Canada
Europe (Type, End User, Treatment)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, End User, Treatment)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, End User, Treatment)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, End User, Treatment)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Johnson & Johnson Vision (Johnson & Johnson Services Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss AG (ZEISS International)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch + Lomb Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rayner Intraocular Lenses Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ophtec BV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperVision Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoya Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Menicon Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bohus BioTech AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifecore Biomedical, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediphacos
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Santen Pharmaceutical Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
UltraVision CLPL
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments